What is the GRIT Study?
The G.R.I.T. Study is the first global app-based registered clinical trial for patients with metabolic disorders. It uses a mobile health journal, Zamplo, to record patient-reported outcome measures (PROMs) in patients with metabolic disorders.www.zamplo.org/
Rare diseases are understudied, leading to a shortage of patient health data. This negatively impacts clinical decision-making as it relies on the collection of sufficient patient health data.
The M.A.G.I.C. Clinic and Zamplo have come together to solve this problem through the G.R.I.T. Study.
Learn about the G.R.I.T. Study from Dr. Khan
Dr. Khan is a Medical Geneticist with more than 16 years of experience diagnosing and treating rare genetic diseases.
Watch the video to learn about the value of the GRIT Study and the Zamplo app the expert himself!
A control group is vital to a clinical studies success: They provide us with a comparison group to evaluate if the app is effective in the current treatment and care for rare disease patients.
We will also learn how effective the current health system is in supporting patients living with rare diseases.
Anyone from anywhere in the world is eligible to participate in the study as long as they:
Unsure if you are eligible? Contact us!